Annual Net Margin
33.96%
+3.34%+10.91%
31 December 2023
Summary:
Halozyme Therapeutics annual net profit margin is currently 33.96%, with the most recent change of +3.34% (+10.91%) on 31 December 2023. During the last 3 years, it has fallen by -14.28% (-29.60%). HALO annual net margin is now -62.62% below its all-time high of 90.84%, reached on 31 December 2021.HALO Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
47.23%
+6.93%+17.20%
30 September 2024
Summary:
Halozyme Therapeutics quarterly net profit margin is currently 47.23%, with the most recent change of +6.93% (+17.20%) on 30 September 2024. Over the past year, it has increased by +9.35% (+24.68%). HALO quarterly net margin is now -29.53% below its all-time high of 67.02%, reached on 30 June 2021.HALO Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.9% | +24.7% |
| 3 y3 years | -29.6% | - |
| 5 y5 years | +164.2% | +187.3% |
HALO Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -62.6% | +10.9% | -27.9% | +217.2% |
| 5 y | 5 years | -62.6% | +164.2% | -29.5% | +173.7% |
| alltime | all time | -62.6% | +100.3% | -29.5% | +100.3% |
Halozyme Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 47.23%(+17.2%) |
| June 2024 | - | 40.30%(+2.8%) |
| Mar 2024 | - | 39.22%(+5.7%) |
| Dec 2023 | 33.96%(+10.9%) | 37.12%(-2.0%) |
| Sept 2023 | - | 37.88%(+12.0%) |
| June 2023 | - | 33.82%(+38.4%) |
| Mar 2023 | - | 24.43%(-23.2%) |
| Dec 2022 | 30.62%(-66.3%) | 31.79%(+7.8%) |
| Sept 2022 | - | 29.49%(+98.1%) |
| June 2022 | - | 14.89%(-70.9%) |
| Mar 2022 | - | 51.25%(-21.7%) |
| Dec 2021 | 90.84%(+88.3%) | 65.46%(-2.3%) |
| June 2021 | - | 67.02%(+113.8%) |
| Mar 2021 | - | 31.34%(-47.9%) |
| Dec 2020 | 48.24%(-230.9%) | 60.12%(+8.5%) |
| Sept 2020 | - | 55.43%(+18.6%) |
| June 2020 | - | 46.75%(-294.2%) |
| Mar 2020 | - | -24.07%(-62.4%) |
| Dec 2019 | -36.86%(-30.3%) | -64.10%(+18.5%) |
| Sept 2019 | - | -54.11%(+44.8%) |
| June 2019 | - | -37.36%(-1286.0%) |
| Mar 2019 | - | 3.15%(-189.2%) |
| Dec 2018 | -52.90%(-366.0%) | -3.53%(-96.8%) |
| Sept 2018 | - | -108.98%(+67.6%) |
| June 2018 | - | -65.03%(-26.9%) |
| Mar 2018 | - | -88.95%(-236.1%) |
| Dec 2017 | 19.89%(-128.3%) | 65.35%(+1416.2%) |
| Sept 2017 | - | 4.31%(-104.7%) |
| June 2017 | - | -91.15%(-18.1%) |
| Mar 2017 | - | -111.26%(+58.4%) |
| Dec 2016 | -70.23%(+194.3%) | -70.22%(-22.7%) |
| Sept 2016 | - | -90.87%(+12.7%) |
| June 2016 | - | -80.62%(+72.9%) |
| Mar 2016 | - | -46.63%(-663.8%) |
| Dec 2015 | -23.86%(-73.7%) | 8.27%(-107.0%) |
| Sept 2015 | - | -117.71%(-1791.2%) |
| June 2015 | - | 6.96%(-108.6%) |
| Mar 2015 | - | -80.94%(+366.2%) |
| Dec 2014 | -90.76% | -17.36%(-87.5%) |
| Sept 2014 | - | -138.85%(+56.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | -88.51%(-60.1%) |
| Mar 2014 | - | -221.86%(+26.1%) |
| Dec 2013 | -152.34%(+20.4%) | -175.92%(+46.0%) |
| Sept 2013 | - | -120.48%(-24.0%) |
| June 2013 | - | -158.52%(-2.7%) |
| Mar 2013 | - | -162.99%(+706.1%) |
| Dec 2012 | -126.53%(+259.0%) | -20.22%(-94.6%) |
| Sept 2012 | - | -375.04%(+107.5%) |
| June 2012 | - | -180.75%(-11.1%) |
| Mar 2012 | - | -203.21%(-73.4%) |
| Dec 2011 | -35.25%(-91.0%) | -763.76%(-3493.0%) |
| Sept 2011 | - | 22.51%(+67.5%) |
| June 2011 | - | 13.44%(-110.5%) |
| Mar 2011 | - | -127.73%(-73.0%) |
| Dec 2010 | -390.79%(-8.5%) | -472.88%(+29.4%) |
| Sept 2010 | - | -365.36%(-3.4%) |
| June 2010 | - | -378.14%(+10.4%) |
| Mar 2010 | - | -342.49%(+74.3%) |
| Dec 2009 | -426.88%(-23.1%) | -196.54%(-57.2%) |
| Sept 2009 | - | -459.25%(-61.6%) |
| June 2009 | - | -1196.22%(+125.2%) |
| Mar 2009 | - | -531.15%(-3.3%) |
| Dec 2008 | -555.15%(-11.7%) | -549.47%(+24.4%) |
| Sept 2008 | - | -441.56%(-42.4%) |
| June 2008 | - | -767.13%(+39.1%) |
| Mar 2008 | - | -551.31%(-15.3%) |
| Dec 2007 | -628.93%(-58.1%) | -650.90%(-12.7%) |
| Sept 2007 | - | -745.46%(+10.0%) |
| June 2007 | - | -677.71%(+63.6%) |
| Mar 2007 | - | -414.37%(-59.6%) |
| Dec 2006 | -1502.63%(-85.6%) | -1026.91%(+2.0%) |
| Sept 2006 | - | -1007.25%(-62.7%) |
| June 2006 | - | -2701.60%(-43.3%) |
| Mar 2006 | - | -4762.75%(-24.3%) |
| Dec 2005 | -10.44 K%(+6396.8%) | -6289.58%(-56.4%) |
| Sept 2005 | - | -14.43 K%(+129.9%) |
| June 2005 | - | -6276.03%(+8232.5%) |
| Sept 2002 | - | -75.32%(-63.3%) |
| June 2002 | - | -205.37%(-733.3%) |
| Mar 2002 | - | 32.43% |
| Dec 2001 | -160.63% | - |
FAQ
- What is Halozyme Therapeutics annual net profit margin?
- What is the all time high annual net margin for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual net margin year-on-year change?
- What is Halozyme Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly net margin year-on-year change?
What is Halozyme Therapeutics annual net profit margin?
The current annual net margin of HALO is 33.96%
What is the all time high annual net margin for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual net profit margin is 90.84%
What is Halozyme Therapeutics annual net margin year-on-year change?
Over the past year, HALO annual net profit margin has changed by +3.34% (+10.91%)
What is Halozyme Therapeutics quarterly net profit margin?
The current quarterly net margin of HALO is 47.23%
What is the all time high quarterly net margin for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly net profit margin is 67.02%
What is Halozyme Therapeutics quarterly net margin year-on-year change?
Over the past year, HALO quarterly net profit margin has changed by +9.35% (+24.68%)